Shareholder plans SNDK (NASDAQ: SNDK) stock sale filing disclosure
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A shareholder associated with SNDK has filed a notice to sell 1,000 shares of common stock through Morgan Stanley Smith Barney, with an indicated aggregate market value of $421,459.40 on NASDAQ. These shares were acquired on 11/15/2021 through restricted stock vesting under a registered plan in exchange for services rendered.
The filing also lists recent sales over the past three months by the Massengill Living Trust, including 2,340 common shares sold on 11/26/2025 for $508,394.95 and 2,816 common shares sold on 01/06/2026 for $953,009.02, among other transactions. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
Positive
- None.
Negative
- None.
FAQ
What does this Form 144 filing for SNDK disclose?
The filing discloses that a shareholder intends to sell 1,000 shares of SNDK common stock on NASDAQ through Morgan Stanley Smith Barney, with an indicated aggregate market value of $421,459.40.
Who is the selling security holder in this SNDK Form 144?
Recent sales disclosed in the notice are attributed to the Massengill Living Trust, which appears as the seller of SNDK common shares in multiple transactions over the past three months.
What SNDK stock sales occurred in the past three months?
The notice lists several sales by the Massengill Living Trust, including 2,340 shares sold on 11/26/2025 for $508,394.95 and 2,816 shares sold on 01/06/2026 for $953,009.02, along with other common stock sales.
What representation does the seller make about SNDK’s information?
By signing the notice, the seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.